Home › Funds › Charles Schwab Investment Management › PRME
Charles Schwab Investment Management position in PRME
PRIME MEDICINE INC · Health Care
Latest position (Q2 2026)927.54K sh
Reported value held$3.42M
Portfolio Weight0.00%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 71.18K | $1.32M | New |
| Q1 2023 | 73.43K | $903.15K | Add |
| Q2 2023 | 141.14K | $2.07M | Add |
| Q3 2023 | 292.57K | $2.79M | Add |
| Q4 2023 | 296.19K | $2.62M | Add |
| Q1 2024 | 297.82K | $2.08M | Add |
| Q2 2024 | 492.26K | $2.53M | Add |
| Q3 2024 | 463.98K | $1.80M | Reduce |
| Q4 2024 | 484.59K | $1.42M | Add |
| Q1 2025 | 503.70K | $1.00M | Add |
| Q2 2025 | 518.63K | $1.28M | Add |
| Q3 2025 | 573.16K | $3.18M | Add |
| Q4 2025 | 936.82K | $3.25M | Add |
| Q1 2026 | 917.21K | $3.19M | Reduce |
| Q2 2026 | 927.54K | $3.42M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRME
- BlackRock Inc 9.60M sh · $35.43M · Q2 2026
- ARK Invest 8.35M sh · $30.81M · Q2 2026
- Vanguard Group 6.47M sh · $22.44M · Q4 2025
- Balyasny Asset Management 3.97M sh · $14.65M · Q2 2026
- Goldman Sachs Group 3.43M sh · $12.66M · Q2 2026
- Casdin Capital 3.17M sh · $11.69M · Q2 2026
- UBS Group AG 2.79M sh · $10.31M · Q2 2026
- Geode Capital Management 2.71M sh · $10.01M · Q2 2026
- Citadel Advisors 2.35M sh · $8.68M · Q2 2026
- Fidelity Management & Research (FMR) 1.76M sh · $6.50M · Q2 2026
- Two Sigma Investments 1.52M sh · $5.63M · Q2 2026
- Farallon Capital Management 1.24M sh · $4.58M · Q2 2026